Navigation Links
Allazo Health CEO at Wharton Health Care Conference Shows how Predictive Analytics and Individualized Intervention Targeting Promote Medication Adherence.
Date:2/15/2013

PHILADELPHIA, Feb. 15, 2013 /PRNewswire/ -- Allazo Health's CEO, Clifford Jones will be presenting at the 19th annual Wharton Health Care Conference today. Other speakers include Bruce Broussard , President and CEO of Humana; Gary L. Gottlieb , MD, President and CEO of Partners HealthCare; and Kent Thiry , Co-Chairman and CEO of DaVita.

During the presentation, Jones will discuss details of Allazo Health's AllazoEngine™ and share data on the impact it has had on improving patients' medication adherence.

Allazo Health's AllazoEngine, is an analytics service that provides an effective and cost-efficient solution to the complex problem of medication non-adherence for health insurers, pharmacy benefit management companies, integrated delivery networks, and accountable care organizations. Allazo Health's unique proprietary technology not only predicts which patients will be non-adherent to each of their medications, but also predicts how individual patients will respond to various types of intervention efforts. Intervention methods, for example calls from a pharmacist when patients start new medications, informational mailings, or automated calls when patients are late to refill their medication, impact medication adherence in different ways for different patients.  By analyzing patient data with its patent pending AllazoEngine, Allazo Health provides clients with an optimal medication adherence intervention strategy targeted to individual patients.

AllazoEngine's analytics financially benefits clients by raising adherence program ROI, reducing medical spending, reducing readmissions, increasing HEDIS scores, and improving Medicare Star ratings.

Jones' experience includes building the Pharmacy Advisor medication adherence program that won awards from URAC and the Pharmacy Benefit Management Institute (PBMI), and has been used with more than 14 million patients.

About Allazo Health:                                                           

Allazo Health is an analytics firm that provides medication adherence solutions and services to health insurers, PBMs, integrated delivery networks, and ACOs. Combining cutting-edge behavioral science research, medication adherence expertise, and predictive analytics, Allazo Health is able to forecast patients' adherence to each of their medications and identify the most effective intervention strategies for individual patients. More information about Allazo Health can be found at http://www.allazohealth.com.

Contact:
Clifford Jones , CEO
cliff@allazohealth.com

About Wharton Health Care Business Conference:

Now in its 19th year, the conference is a leading healthcare forum for industry professionals, policy-makers, and academics. The annual two-day event draws approximately 700 attendees from across the nation. To learn more about the conference, visit http://www.whcbc.org.


'/>"/>
SOURCE Allazo Health
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Proprietary Medical Device Data Helps Businesses Adapt in the Shifting Healthcare Landscape, Post-Affordable Care Act
2. Managed Health Care Associates, Inc. (MHA) Announced as Founding Member Sponsor of The National Association of Specialty Pharmacy (NASP)
3. High Profile HealthCare Companies: Leading Pharma Company Secures New Patents
4. Patient Safety, Science and Technology Summit Inspires Healthcare Industry Stakeholders to Action in Pursuit of 0 Preventable Patient Deaths by 2020
5. Cardinal Health To Acquire AssuraMed, Leading Direct-To-Home Medical Supplies Distributor for $2.07 Billion
6. Hill-Rom to Participate in the 2013 Citi Global Healthcare Conference
7. Baylor University Medical Center activates Allscripts electronic health record system
8. Seven Denver Area Hospitals Join Colorado Health Information Exchange To Support Advancements In Health Care Quality & Safety
9. Dynamic Healthcare Services Names Senior Level Management Team
10. Perrigo Company To Present At The Leerink Swann Global Healthcare Conference
11. Healthcare Fraud Shield Now Offers SIU Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... 20, 2017  Prime Therapeutics LLC (Prime) released this statement ... following today,s Institute for Clinical and Economic Review,s (ICER) ... effectiveness and value of abuse-deterrent formulations (ADF) of opioids. Prime ... at the meeting. ... benefit to the use of abuse-deterrent formulations (ADF) in opioids ...
(Date:7/15/2017)... 15, 2017 Enterin Inc., a Philadelphia ... disease (PD), today announced the completion of a $12.7 million ... Ventures III, as well as the participation of existing investors. ... to have the support of New Ventures III and our ... validation of the potential of our platform technology to transform ...
(Date:7/13/2017)... 2017  Centurion Medical Products, a leader in medical product innovation ... impaction removal device for hospice patient care. ... Centurion Medical Products ... Patient pain management and emotional comfort are part of ... patient pain while preventing unneeded emergency department admission due to severe ...
Breaking Medicine Technology:
(Date:7/21/2017)... (PRWEB) , ... July 21, 2017 , ... ... weeks Nature’s Tears® EyeMist®, the signature product of her research center at Bio-Logic ... the world’s largest population and the greatest number of sufferers of blindness. “We ...
(Date:7/21/2017)... TORONTO, ONTARIO, CANADA (PRWEB) , ... July 21, ... ... may give insight into why concussion rates are on the rise, say researchers ... Annual Meeting today in Toronto, Ontario, Canada. , “The combination of evaluating the ...
(Date:7/20/2017)... ... July 20, 2017 , ... ... and application performance monitoring (APM) solutions, has expanded its footprint inside the ... According to Peter Ohrenberger, sales director at Nastel, “We’ve replaced an existing ...
(Date:7/20/2017)... ATLANTA, Ga. (PRWEB) , ... July 20, 2017 , ... ... and equal access to medicine for everyone affected by diabetes, is teaming up with ... the five-day global event kicks off on July 24th. , “Team Type 1’s ...
(Date:7/20/2017)... ... July 20, 2017 , ... ... Webinar**, Aug. 9, 2017 — 1:30 p.m. – 3:00 p.m. ET, http://www.fdanews.com/mdqualitydata ... and boosting quality. , It’s known as the “CY2016 Annual FDA Medical Device ...
Breaking Medicine News(10 mins):